Skip to main content
$0.20 +0.01 (+2.66%) At close · Jul 29
Market Cap
$55.23M
Shares
280.36M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.20 Open$0.18 Day$0.18–0.19 52W$0.11–0.26 Avg vol 30d390K Short int654K · 0.2% float · 1.0d Short vol80% DataJan 2021–Jul 2026 Filing10-Q · May 6

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 6, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 20.7 · elevated Equity put/call 0.61
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +17%
above
Price vs 50-day avg +9%
above
RSI (14) 51
neutral
MACD trend Negative
52-week position 61%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +16%
trailing
6-month return +59%
trailing
YTD return +26%
this year
Relative strength +53%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Accumulating
Net +$154.3K over 90 days · 0% sells
Short interest Falling
0.23% of float · ▼ -13.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 44
elevated · 0–100
Fundamentals
Excellent
Revenue growth +22%
Y/Y
Gross margin 30%
expanding
EPS growth +41%
Y/Y
Free cash flow $-978.9K
Balance sheet $2.2M
net cash
Quant / Vol
risk profile
Very High
Volatility 84%
annualized · 1-yr
Max drawdown −56%
past year
ATR 7.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+17% Bullish
Price vs 50-day avg
+9% Bullish
RSI (14)
51 Neutral
MACD trend
Negative Bearish
52-week position
61% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Accumulating
Net +$154.3K over 90 days · 0% sells
Short interest Falling
0.23% of float · ▼ -13.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0 Now $0 · 61% 52-wk high $0
vs 200-day avg +17% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LEEEF
Leef Brands Inc.
this stock
$55.23M +26.3% +22.1% 0.2%
TAK
Takeda Pharmaceutical Co Ltd
$54.78B +13.9% 0.1%
GALDY
Galderma Group AG/ADR
$50.38B +4.2% 0.0%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
$45.13B 0.0%
HLN
Haleon plc
$44.37B +1.7% 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
654.4K
Days to cover
1.0d
Change
-98.3K sh
View
Short Volume
Short vol %
80%
As of
Jul 29, 2026
Short Total
View
Fails to Deliver
FTD shares
363.1K
Value
$76.2K
As of
Jul 13, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$154.3K
Buyers / Sellers
2 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$34.8M
Net income (FY)
$-17.6M
EPS diluted
$-0.10
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 2, 2026
This year
5
View
Exempt Offerings
Offering
$110.2K
Filed
May 11, 2021
View

Performance

5D 20D 120D MTD YTD
LEEEF +4.3% +15.9% +58.9% +15.9% +26.3%
SPY -2.4% -2.3% +6.3% -2.3% +7.0%
vs SPY +6.7% +18.2% +52.6% +18.2% +19.3%
Key facts CIK 1711141 CUSIP 52426X203 Visit website